PATHWAY MODULATOR, PHARMACEUTICAL COMPOSITION HAVING SAME, USE THEREOF, AND THERAPEUTIC… Application WO-2022161364-A1 World Intellectual Property Organisation (WIPO) 04 Aug 2022
Uses of dopamine beta-hydroxylase (DBH) inhibitors and serotonin receptor (5-HT… Grant US-11185542-B2 United States of America 30 Nov 2021
USES OF DOPAMINE BETA-HYDROXYLASE (DBH) INHIBITORS AND SEROTONIN RECEPTOR (5-HT… Application WO-2018022823-A1 World Intellectual Property Organisation (WIPO) 01 Feb 2018